Compass Therapeutics
CMPX
CMPX
77 hedge funds and large institutions have $135M invested in Compass Therapeutics in 2023 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 20 increasing their positions, 25 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
24% less capital invested
Capital invested by funds: $177M → $135M (-$42M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
77
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$5.46M | |
| 2 | +$4.41M | |
| 3 | +$613K | |
| 4 |
ECM
Element Capital Management
New York
|
+$458K |
| 5 |
BlackRock
New York
|
+$388K |
Top Sellers
| 1 | -$8.79M | |
| 2 | -$2.46M | |
| 3 | -$1.84M | |
| 4 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$1.13M |
| 5 |
Swiss National Bank
Zurich,
Switzerland
|
-$322K |